Jagsonpal Pharmaceuticals informs about outcome of board meeting

13 Feb 2020 Evaluate

Jagsonpal Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held today, the13th February, 2020), approved and taken on record Un-Audited Financial Results of the Company for the Quarter and nine months ended 31st December, 2019; and Limited Review Report for the Quarter and Nine Months ended 31st December 2019.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

334.70 7.65 (2.34%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.